Wallace Hart LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 51.0% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,292 shares of the medical equipment provider’s stock after selling 1,344 shares during the quarter. Intuitive Surgical accounts for about 0.5% of Wallace Hart LLC’s investment portfolio, making the stock its 9th biggest position. Wallace Hart LLC’s holdings in Intuitive Surgical were worth $674,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in ISRG. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the 4th quarter worth $82,517,000. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its holdings in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. raised its stake in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently issued reports on ISRG. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a report on Monday, January 27th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, CICC Research assumed coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.
Insider Activity at Intuitive Surgical
In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,309 shares of company stock worth $7,611,004. 0.90% of the stock is owned by corporate insiders.
Intuitive Surgical Trading Down 6.9 %
ISRG stock opened at $482.61 on Tuesday. The firm has a 50-day moving average of $570.48 and a two-hundred day moving average of $531.79. The firm has a market capitalization of $171.90 billion, a PE ratio of 75.29, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- How to Invest in Small Cap Stocks
- How to Protect Your Portfolio When Inflation Is Rising
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.